ACTIVE EDGE LIMITED

Financial Health Score: B-

Explanation: ACTIVE EDGE LIMITED is in a stable but weakened condition. While the business is solvent and has no immediate life-threatening financial emergencies (such as insolvency), it has recently suffered a noticeable drop in its overall financial fitness. The significant contraction in net assets and the tripling of short-term liabilities suggest the business experienced a rough patch, requiring a capital injection from the director to stabilize the patient.

Key Vital Signs

• Net Assets (Financial Weight): £40,236 (Down from £49,552) The company’s net worth has dropped by roughly 18.8% in the last year. Think of this as the patient losing a significant amount of healthy body mass. While the business is still in positive equity, this rapid decline indicates an underlying issue—likely a loss-making year—that has eaten into the company's historical reserves.

• Current Liabilities (Short-term Blood Pressure): £9,498 (Up from £3,322) Short-term obligations have nearly tripled. This spike acts like high blood pressure, increasing the immediate strain on the business's cash flow. However, a closer look at the notes reveals much of this is money owed to the director, rather than external creditors, which mitigates the risk of a fatal cash flow event.

• Current Assets (Pulse Rate): £49,356 (Down from £51,272) The company’s short-term assets (cash, debtors, etc.) have seen a slight slowdown. The pulse is still present and steady, but it is weaker than in previous years, indicating a reduced ability to generate immediate cash from operations.

• Director's Loan Account (Blood Transfusion): £10,000 Injected The financial statements reveal the director advanced £10,000 to the company during the year, while only drawing down £896. This is the equivalent of an emergency blood transfusion. The director personally funded the business to keep it alive and cover its short-term debts, which shows commitment but also highlights that the business wasn't self-sustaining during this period.

Diagnosis

Condition: Acute Financial Strain with Owner-Supported Stabilization

The diagnostic data reveals a business that encountered a severe, albeit temporary, financial illness during the 2025 fiscal year. The most glaring symptom is the £9,316 drop in shareholders' funds, meaning the business operated at a loss for the year.

The underlying cause of this distress is not explicitly detailed in the micro-accounts, but the symptoms tell a clear story: the business's operational revenue was insufficient to cover its costs. The drop in employee count from 1 to 0 suggests the director is now running the operation single-handedly, possibly to reduce overheads in response to the financial pressure.

Crucially, the patient survived this episode because of life support from the owner. The tripling of short-term creditors is heavily influenced by the director's £10,000 loan. Without this owner-funded transfusion, the business may have struggled to meet its external obligations. The good news is that the business has no external debt burdens like bank loans, meaning the "high blood pressure" is entirely owed to the owner, who has a vested interest in the patient's survival.

Recommendations

1. Staunch the Bleeding (Return to Profitability): The immediate priority is to stop the haemorrhage of equity. The director must review the cost base and revenue streams to ensure the business returns to a net positive position. Relying on personal director loans is a temporary bandage, not a cure.
2. Rehabilitate Cash Flow: With the business now a solo operation, cash flow forecasting is critical. The director should ensure that seasonal revenues (typical of outdoor sports like paragliding) are carefully managed to cover the leaner winter months without requiring further personal injections.
3. Manage the Director Loan: The £9,210 owed to the director is currently classified as a current liability. If the business cannot repay this within 12 months, it may be worth formally restructuring this as a long-term loan to relieve the immediate "blood pressure" on the balance sheet and provide more breathing room.
4. Routine Health Checks: Given the volatility seen between 2024 and 2025, more frequent financial check-ups are advisable. Monthly management accounts should be reviewed to catch any signs of relapse early.